Compare TYG & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TYG | AMPH |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 971.8M |
| IPO Year | 2003 | 2005 |
| Metric | TYG | AMPH |
|---|---|---|
| Price | $43.82 | $18.72 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $28.38 |
| AVG Volume (30 Days) | 167.8K | ★ 710.6K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | ★ 11.71% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | N/A | $6.90 |
| Revenue Next Year | N/A | $4.64 |
| P/E Ratio | ★ $52.62 | $137.93 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $40.28 | $16.65 |
| 52 Week High | $51.18 | $31.26 |
| Indicator | TYG | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 30.12 | 44.87 |
| Support Level | $42.34 | $16.84 |
| Resistance Level | $43.96 | $20.08 |
| Average True Range (ATR) | 0.79 | 0.80 |
| MACD | -0.28 | 0.11 |
| Stochastic Oscillator | 2.03 | 73.53 |
Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.